Effect of Rehabilitation on Ejection Fraction (FE) in Cardiopathic and Non Cardiopathic Patients Undergoing Major Orthopedic Surgery
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03413345
Recruitment Status : Unknown
Verified November 2017 by Istituto Ortopedico Galeazzi. Recruitment status was: Recruiting
It is a trial aimed to evaluate the ejection fraction in the preoperative phase and during follow-up in two groups of subjects undergoing major orthopedic surgery: the first consisting of subjects without history of cardiac disease, and the second from subjects with a history of cardiopulmonary disease
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
the population consists of 188 subjects (94 subjects for the cardiopathic arm and 94 subjects for the non-cardiopathic arm) undergoing to major orthopedic surgery (hip and knee prosthesis)
Age: < or equal 18 and > or equal 85 years
major orthopedic surgery
rehabilitation at our site
a positive history for the cardiopathic group
Age: > 85 and < 18
impossibility to participate to the rehabilitative protocol or come to the follow up visit
lack of consensus
previous acute cerebrovascular and / or cardiological events within 6 months prior to enrollment
previous myocardial (percutaneous and / or surgical) revascularization interventions within the 6 months prior to enrollment
previous (even in pediatric age) interventions of surgical correction of congenital heart disease